Filter announcements
Loading...
Incorporated in 2003, Infinium Pharmachem Ltd manufactures and sells Iodian based Pharmaceutical Intermediates
Infinium Pharmachem has commissioned its new contrast media raw materials facility, a key forward integration. This move targets ₹100 Cr annual revenue within 3 years at ~30% EBITDA margin, expected to boost blended EBITDA to ~20%.